Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptor

Biochemical Journal

Volumn 380, Issue 2, 2004, Pages 561-569

  Kobayashi, Shigeki ^a   Yamamoto, Takeshi ^a,d   Parness, Jerome ^b   Ikemoto, Noriaki ^a,c  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Domain domain interaction; Domain specific anti body; Excitation contraction coupling; Ryanodine receptor (RyR)

Indexed keywords

ACTIVATION ANALYSIS; ANTIBODIES; CALCIUM; MUTAGENESIS; POLYPEPTIDES;

CHANNEL REGULATION; DOMAIN PEPTIDES (DP); MALIGNANT HYPERTHERMIA (MH);

BIOCHEMISTRY;

CALCIUM CHANNEL; POLYCLONAL ANTIBODY; POLYLYSINE; RYANODINE RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; FLUORESCENCE; MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; RABBIT; SARCOPLASMIC RETICULUM; SENSITIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; CALCIUM; CALCIUM CHANNELS; MALIGNANT HYPERTHERMIA; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCLE, SKELETAL; PEPTIDES; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TRITIUM;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 2942711417     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20040112     Document Type: Article

References (53)

1. Rios, E. and Pizarro, G. (1991) Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol. Rev. 71, 849-908
2. Rios, E., Pizarro, G. and Stefani, E. (1992) Charge movement and the nature of signal transduction in skeletal muscle excitation-contraction coupling. Annu. Rev. Physiol. 54, 109-133
3. Schneider, M. F. (1994) Control of calcium release in functioning skeletal muscle fibers. Annu. Rev. Physiol. 56, 463-484
4. 2+ release channels and their regulation by endogenous effectors. Annu. Rev. Physiol. 56, 485-508
5. 2+ ions in excitation-contraction coupling of skeletal muscle fibres. Biochem. Biophys. Acta. 1241, 59-116
6. El-Hayek, R., Antoniu, B., Wang, J., Hamilton, S. L. and Ikemoto, N. (1995) Identification of calcium release-triggering and blocking regions of the II-III loop of the skeletal muscle dihydropyridine receptor. J. Biol. Chem. 270, 22116-22118
7. El-Hayek, R. and Ikemoto, N. (1998) Identification of the minimum essential region in the II-III loop of the dihydropyridine receptor α1 subunit required for activation of skeletal muscle-type excitation-contraction coupling. Biochemistry 37, 7015-7020
8. El-Hayek, R., Saiki, Y., Yamamoto, T. and Ikemoto, N. (1999) Identification of calcium release-triggering and blocking regions of the II-III loop of the skeletal muscle dihydropyridine receptor. J. Biol. Chem. 274, 33341-33347
9. 760 region of the dihydropyridine receptor II-III loop in skeletal muscle-type excitation-contraction coupling. J. Biol. Chem. 274, 7825-7832
10. 2+-dependent manner, but peptide A is required for the functions of peptide C. J. Biol. Chem. 277, 993-1001
11. Yamamoto, T. and Ikemoto, N. (2002) T-tubule depolarization-induced local events in the ryanodine receptor, as monitored with the fluorescent conformational probe incorporated by mediation of peptide A. J. Biol. Chem. 277, 984-992
12. 2+ regulating proteins. Curr. Mol. Med. 2, 347-369
13. 2+ release channels? Trends. Cardiovasc. Med. 12, 189-197
14. 2+ regulation defects. Physiol. Rev. 76, 537-592
15. Jurkatt-Rott, K., McCarthy, T. and Lehmann-Horn, F. (2000) Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 23, 4-17
16. 2+ regulation. Biosci. Rep. 21, 155-168
17. 2+ release channels. Am. J. Med. 104, 470-466
18. McCarthy, T. V., Quane, K. A. and Lynch, P. J. (2000) Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum. Mutat. 15, 410-417
19. Sambuughin, N., Nelson, T. E., Jankovic. J., Xin, C., Meissner, G., Mullakandov, M., Ji, J., Rosenberg, H., Sivakumar, K. and Goldfarb, L. G. (2001) Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families. Neuromuscul. Disord. 11, 530-537
20. Froemming, G. R. and Ohlendieck, K. (2001) The role of ion-regulatory membrane proteins of excitation-contraction coupling and relaxation in inherited muscle diseases. Front. Biosci. 6, D65-D74
21. 2+ signaling and muscle disease. Eur. J. Biochem. 267, 5291-5297
22. Sanbuughin, N., MacWilliams, S., de Bantel, A., Sivakumar, K. and Nelson, T. E. (2001) Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype. Am. J. Hum. Genet. 69, 204-208
23. Brown, R. L., Pollack, A. N., Couchman, K. G., Hodges, M., Hutchinson, D. O., Waaka, R., Lynch, P., McCarthy, T. V. and Stowell, K. M. (2000) A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree. Hum. Mol. Genet. 9, 1515-1524
24. Monnier, N., Romero, N. B., Lerale, J., Landrieu, P., Nivoche, Y., Fardeau, M. and Lunardi, J. (2001) Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor. Hum. Mol. Genet. 10, 2581-2592
25. Rueffert, H., Kraus, H., Olthoff, D., Deutrich, C. and Froster, U. G. (2001) Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia. Hum. Mutat. 17, 238
26. Scacheri, P. C., Hoffmann, E. P. and Fratkin, J. D. (2000) A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology 55, 1689-1696
27. Tilgen, N., Zorzato, F., Halliger-Keller, B., Muntoni, F., Sewry, C., Palmucci, L. M., Schneider, C., Hauser, E., Lehmann-Horn, F., Müller, C. R. and Treves, S. (2001) Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum. Mol. Genet. 10, 2879-2887
28. 2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease. J. Biol. Chem. 272, 26332-26339
29. Yang, T., Ta, T. A., Pessah, I. N. and Allen, P. D. (2003) Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J. Biol. Chem. 278, 25722-25730
30. 2+ channel regulation. J. Biol. Chem. 275, 11618-11625
31. Yamamoto, T. and Ikemoto, N. (2002) Spectroscopic monitoring of local conformational changes during the intramolecular domain-domain interaction of the ryanodine receptor. Biochemistry 41, 1492-1501
32. Ikemoto, N. and Yamamoto, T. (2002) Regulation of calcium release by interdomain interaction within ryanodine receptors. Front. Biosci. 7, 671-683
33. 2+ spark frequency in skeletal muscle. J. Gen. Physiol. 116, 15-31
34. 2+ release in skinned skeletal muscle fibers. Am. J. Physiol. Cell Physiol. 281, C207-C214
35. 2+ release by direct and specific action at skeletal muscle ryanodine receptors. J. Biol. Chem. 272, 26965-26971
36. 3H]azidodantrolene by photoaffinity labeling. Biochemistry 40, 531-542
37. Paul-Pletzer, K., Yamamoto, T., Bhat, M. B., Ma, J., Ikemoto, N., Jimenez, L. S., Morimoto, H., Williams, P. G. and Parness, J. (2002) Identification of adantrolene-binding sequence on the skeletal muscle ryanodine receptor. J. Biol. Cnem. 277, 34918-34923
38. Ikemoto, N., Kim, D. H. and Antoniu, B. (1988) Measurement of calcium release in isolated membrane systems: coupling between the transverse tubule and sarcoplasmic reticulum. Methods Enzymol. 157, 469-480
39. Domen, P., Nevens, J., Mallia, K., Hermanson, G. and Klenk, D. (1990) Site-directed immobilization of proteins. J. Chromatogr. 510, 293-302
40. El-Hayek, R., Lokuta, A. J., Arevalo, C. and Valdivia, H. H. (1995) Peptide probe of ryanodine receptor function. Imperatoxin A, a peptide from the venom of the scorpion Pandinus imperator, selectively activates skeletal-type ryanodine receptor isoforms. J. Biol. Chem. 270, 28696-28704
41. 2+ release from sarcoplasmic reticulum. J. Biol. Chem. 270, 3017-3021
42. Kang, J. J., Tarcsafalvi, A., Carlos, A. D., Fujimoto, E., Shahrokh, Z., Thevenin, B. J., Shohet, S. B. and Ikemoto, N. (1992) Conformational changes in the foot protein of the sarcoplasmic reticulum assessed by site-directed fluorescent labeling. Biochemistry 31, 3288-3293
43. Lakowicz, J. R. (1983) Principles of Fluorescence Spectroscopy, pp. 258-301, Plenum Press, New York
44. 2+ release channel. J. Membr. Biol. 161, 33-43
45. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 271, 22759-22763
46. Laitinen, P. J., Brown, K. M., Piippo, K., Swan, H., Devaney, J. M., Brahmbhatt, B., Donarum, E. A., Marino, M., Tiso, N., Viitasalo, M. et al. (2001) Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103, 485-190
47. Tiso, N., Stephan, D. A., Nava, A., Bagattin, A., Devaney, J. M., Stanchi, F., Larderet, Brahmbhatt, B., Brown, K., Bauce, B. et al. (2001) Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10, 189-194
48. Priori, S. G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R., Sorrento, V. and Danieli, G. A. (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103, 196-200
49. Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R. et al. (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106, 69-74
50. Bauce, B., Rampazzo, A., Basso, C., Bagattin, A., Daliento, L., Tiso, N., Turrini, P., Thiene, G., Danieli, G. A. and Nava, A. (2002) Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J. Am. Coll. Cardiol. 40, 341-349
51. Marks, A. R., Priori, S., Memmi, M., Kontula, K. and Laitinen, P. J. (2002) Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J. Cell. Physiol. 190, 1-6
52. Allen, P. D. (2002) Leaky 'feet' and sudden death. Circ. Res. 91, 181-182
53. 2+ release channel. J. Biol. Chem. 262, 6460-6463